1021 related articles for article (PubMed ID: 24938824)
1. Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease.
Smart NA; Dieberg G; Ladhani M; Titus T
Cochrane Database Syst Rev; 2014 Jun; (6):CD007333. PubMed ID: 24938824
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of early versus late nephrology referral in chronic kidney disease: a systematic review.
Smart NA; Titus TT
Am J Med; 2011 Nov; 124(11):1073-80.e2. PubMed ID: 22017785
[TBL] [Abstract][Full Text] [Related]
3. Dietary interventions for adults with chronic kidney disease.
Palmer SC; Maggo JK; Campbell KL; Craig JC; Johnson DW; Sutanto B; Ruospo M; Tong A; Strippoli GF
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011998. PubMed ID: 28434208
[TBL] [Abstract][Full Text] [Related]
4. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
[TBL] [Abstract][Full Text] [Related]
5. Antioxidants for chronic kidney disease.
Jun M; Venkataraman V; Razavian M; Cooper B; Zoungas S; Ninomiya T; Webster AC; Perkovic V
Cochrane Database Syst Rev; 2012 Oct; 10(10):CD008176. PubMed ID: 23076940
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive agents for treating IgA nephropathy.
Vecchio M; Bonerba B; Palmer SC; Craig JC; Ruospo M; Samuels JA; Molony DA; Schena FP; Strippoli GF
Cochrane Database Syst Rev; 2015 Aug; (8):CD003965. PubMed ID: 26235292
[TBL] [Abstract][Full Text] [Related]
7. Aldosterone antagonists for preventing the progression of chronic kidney disease.
Bolignano D; Palmer SC; Navaneethan SD; Strippoli GF
Cochrane Database Syst Rev; 2014 Apr; (4):CD007004. PubMed ID: 24782282
[TBL] [Abstract][Full Text] [Related]
8. Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease.
Nistor I; Palmer SC; Craig JC; Saglimbene V; Vecchio M; Covic A; Strippoli GF
Cochrane Database Syst Rev; 2015 May; 2015(5):CD006258. PubMed ID: 25993563
[TBL] [Abstract][Full Text] [Related]
9. Urgent-start peritoneal dialysis versus haemodialysis for people with chronic kidney disease.
Htay H; Johnson DW; Craig JC; Teixeira-Pinto A; Hawley CM; Cho Y
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD012899. PubMed ID: 33501650
[TBL] [Abstract][Full Text] [Related]
10. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
11. Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease.
Rabindranath KS; Strippoli GF; Daly C; Roderick PJ; Wallace S; MacLeod AM
Cochrane Database Syst Rev; 2006 Oct; (4):CD006258. PubMed ID: 17054289
[TBL] [Abstract][Full Text] [Related]
12. Thyroid hormones for acute kidney injury.
Nigwekar SU; Strippoli GF; Navaneethan SD
Cochrane Database Syst Rev; 2013 Jan; (1):CD006740. PubMed ID: 23440810
[TBL] [Abstract][Full Text] [Related]
13. Oral adsorbents for preventing or delaying the progression of chronic kidney disease.
Wu HM; Sun HJ; Wang F; Yang M; Dong BR; Liu GJ
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD007861. PubMed ID: 25317905
[TBL] [Abstract][Full Text] [Related]
14. Treatment for peritoneal dialysis-associated peritonitis.
Ballinger AE; Palmer SC; Wiggins KJ; Craig JC; Johnson DW; Cross NB; Strippoli GF
Cochrane Database Syst Rev; 2014 Apr; (4):CD005284. PubMed ID: 24771351
[TBL] [Abstract][Full Text] [Related]
15. Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease.
Strippoli GF; Navaneethan SD; Craig JC
Cochrane Database Syst Rev; 2006 Oct; (4):CD003967. PubMed ID: 17054191
[TBL] [Abstract][Full Text] [Related]
16. Steroid avoidance or withdrawal for pancreas and pancreas with kidney transplant recipients.
Montero N; Webster AC; Royuela A; Zamora J; Crespo Barrio M; Pascual J
Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD007669. PubMed ID: 25220222
[TBL] [Abstract][Full Text] [Related]
17. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
[TBL] [Abstract][Full Text] [Related]
18. Early versus delayed erythropoietin for the anaemia of end-stage kidney disease.
Coronado Daza J; Martí-Carvajal AJ; Ariza García A; Rodelo Ceballos J; Yomayusa González N; Páez-Canro C; Loza Munárriz C; Urrútia G
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD011122. PubMed ID: 26671531
[TBL] [Abstract][Full Text] [Related]
19. HMG CoA reductase inhibitors (statins) for dialysis patients.
Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Nigwekar SU; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2013 Sep; 2013(9):CD004289. PubMed ID: 24022428
[TBL] [Abstract][Full Text] [Related]
20. Pentoxifylline for diabetic kidney disease.
Shan D; Wu HM; Yuan QY; Li J; Zhou RL; Liu GJ
Cochrane Database Syst Rev; 2012 Feb; (2):CD006800. PubMed ID: 22336824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]